These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 4878333

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Cytostatic and antimetabolite therapy in chronic inflammatory joint diseases and collagen diseases].
    Chlud K.
    Munch Med Wochenschr; 1969 Aug 08; 111(32):1626-9. PubMed ID: 5394967
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Evaluation of immunosuppressive therapy with podophyllin derivatives in the treatment of primary chronic polyarthritis].
    Szántó L.
    Z Gesamte Inn Med; 1969 Jan 01; 24(1):Suppl:154. PubMed ID: 5402573
    [No Abstract] [Full Text] [Related]

  • 5. [Evaluation of immunosuppressive therapy with podophyllin derivatives in the treatment of primary chronic polyarthritis].
    Szántó L.
    Z Gesamte Inn Med; 1969 May 15; 24(10):154. PubMed ID: 5807426
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [New possibilities in testing resistance of human carcinoma tissue to cytostatic agents in vivo].
    Heckmann U.
    Dtsch Med Wochenschr; 1967 May 19; 92(20):932-5 passim. PubMed ID: 4960735
    [No Abstract] [Full Text] [Related]

  • 9. [Changes in the synovial fluid following intra-articular injections of Proresid].
    Vojtísek O, Freund U, Greiling H.
    Fysiatr Revmatol Vestn; 1969 Dec 19; 47(6):275-80. PubMed ID: 4188551
    [No Abstract] [Full Text] [Related]

  • 10. [Prevention of experimental arthritis with the cytostatic agent podophyllinic acid ethylhydrazide].
    Szántó L, Lörincz G, Gömör B.
    Arzneimittelforschung; 1968 Jul 19; 18(7):886-9. PubMed ID: 5756046
    [No Abstract] [Full Text] [Related]

  • 11. [Studies with Proresid (SP-I) in various transplantable tumors].
    Cerletti A, Stähelin H, Schoch J.
    Med Klin; 1966 Jul 29; 61(30):1192-4. PubMed ID: 5993141
    [No Abstract] [Full Text] [Related]

  • 12. [Considerations on the use of Proresid (SPI-SPG Sandoz) as an adjuvant in the treatment of tumors (preliminart communication)].
    Motti VJ.
    Hospital (Rio J); 1968 Oct 29; 74(4):1377-88. PubMed ID: 5304166
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Problems in combined radio-cytostatic therapy. 7. Syncarcinolytic studies using 5-fluorouracil, natulan and proresid in Crocker sarcoma 180 of mice].
    Ringleb D, Krieg R, Sauer D.
    Strahlentherapie; 1969 Oct 29; 138(4):423-8. PubMed ID: 5352491
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Therapy of progressive chronic polyarthritis with cytostatic agents].
    Jesserer H.
    Wien Klin Wochenschr; 1968 Mar 08; 80(10):187-91. PubMed ID: 5650710
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [The effect of Proresid on the growth and formation of metastases of the RBI-sarcoma in rats].
    Svec F, Altaner C.
    Med Klin; 1968 Dec 27; 63(52):2119-25. PubMed ID: 5729222
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.